{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:58:20Z","timestamp":1773914300589,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1185354"],"award-info":[{"award-number":["APP1185354"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001215","name":"La Trobe University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001215","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["MCRF21011"],"award-info":[{"award-number":["MCRF21011"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijpddr.2025.100627","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:38:50Z","timestamp":1764981530000},"page":"100627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel heterospirocyclic antimalarials with activity against artemisinin- and multidrug-resistant P. falciparum malaria"],"prefix":"10.1016","volume":"29","author":[{"given":"Liana","family":"Theodoridis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6654-7266","authenticated-orcid":false,"given":"Carlo","family":"Giannangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farrah","family":"El-Saafin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MR Ranga","family":"Prabhath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3694-3989","authenticated-orcid":false,"given":"Christopher A.","family":"Macraild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5226-7864","authenticated-orcid":false,"given":"Pallavi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7497-7082","authenticated-orcid":false,"given":"Darren J.","family":"Creek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-371X","authenticated-orcid":false,"given":"Teresa G.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijpddr.2025.100627_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ijpddr.2025.100627_bib2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1021\/np9002564","article-title":"Antimalarial benzylisoquinoline alkaloid from the rainforest tree Doryphora sassafras","volume":"72","author":"Buchanan","year":"2009","journal-title":"J. Nat. Prod."},{"issue":"2","key":"10.1016\/j.ijpddr.2025.100627_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/infdis\/jiv372","article-title":"Metabolic dysregulation induced in Plasmodium falciparum by dihydroartemisinin and other front-line antimalarial drugs","volume":"213","author":"Cobbold","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.ijpddr.2025.100627_bib4","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1128\/AAC.01226-16","article-title":"Metabolomics-based screening of the malaria box reveals both novel and established mechanisms of action","volume":"60","author":"Creek","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ijpddr.2025.100627_bib5","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/bioinformatics\/bts069","article-title":"IDEOM: an excel interface for analysis of LC\u2013MS-based metabolomics data","volume":"28","author":"Creek","year":"2012","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.ijpddr.2025.100627_bib6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1586\/eri.09.68","article-title":"Discovery, mechanisms of action and combination therapy of artemisinin","volume":"7","author":"Cui","year":"2009","journal-title":"Expert Rev. Anti-infect. Ther."},{"issue":"8","key":"10.1016\/j.ijpddr.2025.100627_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105217","article-title":"Evaluation of antimalarial activity and toxicity of a new primaquine prodrug","volume":"9","author":"Davanco","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijpddr.2025.100627_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","article-title":"Artemisinin resistance: current status and scenarios for containment","volume":"8","author":"Dondorp","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"8","key":"10.1016\/j.ijpddr.2025.100627_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.pt.2021.04.006","article-title":"Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials","volume":"37","author":"Duffey","year":"2021","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100627_bib10","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80813","article-title":"Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway","volume":"11","author":"Edgar","year":"2022","journal-title":"eLife"},{"issue":"7","key":"10.1016\/j.ijpddr.2025.100627_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ijpara.2008.03.004","article-title":"In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes","volume":"38","author":"Ekland","year":"2008","journal-title":"Int. J. Parasitol."},{"issue":"7","key":"10.1016\/j.ijpddr.2025.100627_bib12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0006-2952(92)90213-3","article-title":"Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1, 4-naphthoquinone (566C80)","volume":"43","author":"Fry","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpddr.2025.100627_bib13","doi-asserted-by":"crossref","first-page":"RP92990","DOI":"10.7554\/eLife.92990.3","article-title":"Chemoproteomics validates selective targeting of plasmodium M1 alanyl aminopeptidase as an antimalarial strategy","volume":"13","author":"Giannangelo","year":"2024","journal-title":"eLife"},{"issue":"6","key":"10.1016\/j.ijpddr.2025.100627_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008485","article-title":"System-wide biochemical analysis reveals ozonide antimalarials initially act by disrupting Plasmodium falciparum haemoglobin digestion","volume":"16","author":"Giannangelo","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpddr.2025.100627_bib15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100627_bib16","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s00432-014-1771-7","article-title":"Synergic effects of artemisinin and resveratrol in cancer cells","volume":"140","author":"Li","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.ijpddr.2025.100627_bib17","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.1073\/pnas.0601876103","article-title":"Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems","volume":"103","author":"Liu","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100627_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s42003-020-01424-z","article-title":"Human Aurora kinase inhibitor hesperadin reveals epistatic interaction between Plasmodium falciparum PfArk1 and PfNek1 kinases","volume":"3","author":"Morahan","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ijpddr.2025.100627_bib19","series-title":"World Malaria Report 2024","author":"Organization","year":"2024"},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100627_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02143-20","article-title":"Atypical molecular basis for drug resistance to mitochondrial function inhibitors in Plasmodium falciparum","volume":"65","author":"Painter","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7131","key":"10.1016\/j.ijpddr.2025.100627_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature05572","article-title":"Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum","volume":"446","author":"Painter","year":"2007","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ijpddr.2025.100627_bib22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4269\/ajtmh.1994.51.648","article-title":"A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro","volume":"51","author":"Peel","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100627_bib23","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/acs.joc.0c02424","article-title":"Synthesis of biologically active heterospirocycles through iterative 1, 3-dipolar cycloaddition pathways","volume":"86","author":"Sharma","year":"2020","journal-title":"J. Org. Chem."},{"issue":"7","key":"10.1016\/j.ijpddr.2025.100627_bib24","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.3390\/molecules200712841","article-title":"Three-dimensional compound comparison methods and their application in drug discovery","volume":"20","author":"Shin","year":"2015","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100627_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.molbiopara.2008.01.002","article-title":"A drug-selected Plasmodium falciparum lacking the need for conventional electron transport","volume":"159","author":"Smilkstein","year":"2008","journal-title":"Mol. Biochem. Parasitol."},{"issue":"6220","key":"10.1016\/j.ijpddr.2025.100627_bib26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2025.100627_bib27","article-title":"Antimalarial drug resistance and drug discovery: learning from the past to innovate the future","volume":"28","author":"Theodoridis","year":"2025","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"4254","key":"10.1016\/j.ijpddr.2025.100627_bib28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.ijpddr.2025.100627_bib29","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/emboj\/17.14.3807","article-title":"Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria","volume":"17","author":"Triglia","year":"1998","journal-title":"EMBO J."},{"issue":"6272","key":"10.1016\/j.ijpddr.2025.100627_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/345253a0","article-title":"Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross","volume":"345","author":"Wellems","year":"1990","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ijpddr.2025.100627_bib31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parint.2016.06.013","article-title":"In vitro inhibition of Toxoplasma gondii by the anti-malarial candidate, 6-(1, 2, 6, 7-tetraoxaspiro [7.11] nonadec-4-yl) hexan-1-ol","volume":"65","author":"Xin","year":"2016","journal-title":"Parasitol. Int."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:03:22Z","timestamp":1773896602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320725000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S2211320725000508"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100627","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel heterospirocyclic antimalarials with activity against artemisinin- and multidrug-resistant P. falciparum malaria","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100627"}}